183 related articles for article (PubMed ID: 34097774)
21. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
23. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
24. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
[TBL] [Abstract][Full Text] [Related]
25. Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease.
Ordoñez-Parra J; Mejía Cortes M; Tamayo-Buendía MM; Infante Gómez AM
An Bras Dermatol; 2021; 96(3):388-390. PubMed ID: 33849755
[No Abstract] [Full Text] [Related]
26. Ocular Involvement Preceded the Onset of Cutaneous Lesions in Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Case Report.
Zeng R; Du L; Wang D
Ocul Immunol Inflamm; 2022 Feb; 30(2):320-323. PubMed ID: 33021425
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
29. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
Front Immunol; 2022; 13():915986. PubMed ID: 35990691
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
31. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.
Sangueza M; Plaza JA
J Am Acad Dermatol; 2013 Jul; 69(1):112-9. PubMed ID: 23541598
[TBL] [Abstract][Full Text] [Related]
32. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
33. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection.
Heo EP; Park SH; Kim TH
Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510
[TBL] [Abstract][Full Text] [Related]
34. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
Zeng Y; Fu L; Jin H; Sun Q; Wang B
Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
[TBL] [Abstract][Full Text] [Related]
35. Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma.
Lyapichev KA; Sukswai N; Wang XI; Khoury JD; Medeiros LJ
Am J Dermatopathol; 2020 Sep; 42(9):714-716. PubMed ID: 31313696
[No Abstract] [Full Text] [Related]
36. Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis.
Chang L; Zhang C; Lu J; Shen J; Hamal K; Liu D
Infect Drug Resist; 2023; 16():1545-1559. PubMed ID: 36960391
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
38. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults.
Rodríguez-Pinilla SM; Barrionuevo C; Garcia J; Martínez MT; Pajares R; Montes-Moreno S; Casavilca S; Montes J; Bravo F; Zaharia M; Zevallos-Giampietri E; Sanchez L; Piris MA
Am J Surg Pathol; 2010 Dec; 34(12):1773-82. PubMed ID: 21107082
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological analysis of the hydroa vacciniforme-like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T-cell lymphoma.
Wang GN; Cui Y; Zhao WG; Li L; Zhang XD; Chang Y; Gao XZ; Li Y; Zhang MZ; Li WC
Exp Ther Med; 2018 Dec; 16(6):4772-4778. PubMed ID: 30542432
[TBL] [Abstract][Full Text] [Related]
40. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador.
Montalvo N; Redrobán L
Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
